Laurent Pharma to participate to BIO International Convention
Laurent Pharma to participate to BIO International Convention, June 3-6 2024, San Diego, CA, USA
Laurent Pharmaceuticals Receives Health Canada’s Approval to Initiate Phase 2/3 Clinical Trial in Long COVID
The ESSOR study is a natural extension to our ongoing evaluation of LAU-7b as a next-generation COVID-19 therapeutic, which generated positive results in patients with acute COVID-19 infection and is…
Laurent Pharma to participate to BIO International Convention
Laurent Pharma to participate to BIO International Convention, June 5-8, 2023, Boston, MA